These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 23287864)
1. The role of chromatin modifiers in normal and malignant hematopoiesis. Butler JS; Dent SY Blood; 2013 Apr; 121(16):3076-84. PubMed ID: 23287864 [TBL] [Abstract][Full Text] [Related]
2. Epigenetics of hematopoiesis and hematological malignancies. Hu D; Shilatifard A Genes Dev; 2016 Sep; 30(18):2021-2041. PubMed ID: 27798847 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation of normal and malignant hematopoiesis. Rice KL; Hormaeche I; Licht JD Oncogene; 2007 Oct; 26(47):6697-714. PubMed ID: 17934479 [TBL] [Abstract][Full Text] [Related]
4. Epigenetics in normal and malignant hematopoiesis: An overview and update 2017. Goyama S; Kitamura T Cancer Sci; 2017 Apr; 108(4):553-562. PubMed ID: 28100030 [TBL] [Abstract][Full Text] [Related]
5. Impact of DNA methylation programming on normal and pre-leukemic hematopoiesis. Langstein J; Milsom MD; Lipka DB Semin Cancer Biol; 2018 Aug; 51():89-100. PubMed ID: 28964938 [TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell development: an epigenetic journey. Cullen SM; Mayle A; Rossi L; Goodell MA Curr Top Dev Biol; 2014; 107():39-75. PubMed ID: 24439802 [TBL] [Abstract][Full Text] [Related]
7. Emerging concepts of epigenetic dysregulation in hematological malignancies. Ntziachristos P; Abdel-Wahab O; Aifantis I Nat Immunol; 2016 Sep; 17(9):1016-24. PubMed ID: 27478938 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic control of hematopoiesis: the PU.1 chromatin connection. van Riel B; Rosenbauer F Biol Chem; 2014 Nov; 395(11):1265-74. PubMed ID: 25205721 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic modifiers in normal and malignant hematopoiesis. Haladyna JN; Yamauchi T; Neff T; Bernt KM Epigenomics; 2015; 7(2):301-20. PubMed ID: 25942537 [TBL] [Abstract][Full Text] [Related]
10. Epigenetics in the hematologic malignancies. Fong CY; Morison J; Dawson MA Haematologica; 2014 Dec; 99(12):1772-83. PubMed ID: 25472952 [TBL] [Abstract][Full Text] [Related]
11. DNA methylation in normal and malignant hematopoiesis. Celik H; Kramer A; Challen GA Int J Hematol; 2016 Jun; 103(6):617-26. PubMed ID: 26943352 [TBL] [Abstract][Full Text] [Related]
12. Polycomb complexes PRC1 and their function in hematopoiesis. Vidal M; Starowicz K Exp Hematol; 2017 Apr; 48():12-31. PubMed ID: 28087428 [TBL] [Abstract][Full Text] [Related]
13. Chromatin module inference on cellular trajectories identifies key transition points and poised epigenetic states in diverse developmental processes. Roy S; Sridharan R Genome Res; 2017 Jul; 27(7):1250-1262. PubMed ID: 28424352 [TBL] [Abstract][Full Text] [Related]
14. Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger. Wang GG; Song J; Wang Z; Dormann HL; Casadio F; Li H; Luo JL; Patel DJ; Allis CD Nature; 2009 Jun; 459(7248):847-51. PubMed ID: 19430464 [TBL] [Abstract][Full Text] [Related]
15. Deregulation of histone-modifying enzymes and chromatin structure modifiers contributes to glioma development. Maleszewska M; Kaminska B Future Oncol; 2015 Sep; 11(18):2587-601. PubMed ID: 26289459 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic mechanisms regulating normal and malignant haematopoiesis: new therapeutic targets for clinical medicine. Bonifer C; Bowen DT Expert Rev Mol Med; 2010 Feb; 12():e6. PubMed ID: 20152067 [TBL] [Abstract][Full Text] [Related]
18. Polycomb complexes in normal and malignant hematopoiesis. Di Carlo V; Mocavini I; Di Croce L J Cell Biol; 2019 Jan; 218(1):55-69. PubMed ID: 30341152 [TBL] [Abstract][Full Text] [Related]
19. DNA methylation in hematopoietic development and disease. Gore AV; Weinstein BM Exp Hematol; 2016 Sep; 44(9):783-790. PubMed ID: 27178734 [TBL] [Abstract][Full Text] [Related]